Charles Spungen (@geographer847) 's Twitter Profile
Charles Spungen

@geographer847

ID: 72743091

calendar_today09-09-2009 02:39:24

355 Tweet

61 Followers

637 Following

Charles Spungen (@geographer847) 's Twitter Profile Photo

$BEAM is perfect for accumulation at this price. Sentiment terrible. No near term catalysts. Copycats abound. Reputation for being slow. But realistically they have best tech and best chance to succeed. If BE has a future (likely), BeamTX will be another $ALNY.

Charles Spungen (@geographer847) 's Twitter Profile Photo

Twitter sucks. To check on $beam therapeutics requires a search term with 20 minus signs trailing after, and it has to be updated and lengthened continuously. Also, calling a bottom. What cannot possibly be factored in at this point?

Broad Institute (@broadinstitute) 's Twitter Profile Photo

A new one-time base-editing treatment for spinal muscular atrophy — a neuromuscular disease that is the leading genetic cause of infant mortality — restored motor function and extended lifespan in a mouse model. broad.io/SMAbaseediting

A new one-time base-editing treatment for spinal muscular atrophy — a neuromuscular disease that is the leading genetic cause of infant mortality — restored motor function and extended lifespan in a mouse model.
broad.io/SMAbaseediting
Charles Spungen (@geographer847) 's Twitter Profile Photo

Re $BEAM, while gen feeling is 2024 might be catalyst rich, there's also sense that the company & tech will grow increasingly irrelevant due to lateness to market with key drugs and copycat companies. Market sending clear signal.

Charles Spungen (@geographer847) 's Twitter Profile Photo

No further explanation needed as to why $beam and similarly situated biotech stocks have collapsed. wsj.com/articles/inves…

Charles Spungen (@geographer847) 's Twitter Profile Photo

Economist special tech session on #CRISPR $edit $prme $crsp $beam $ntla CRISPR technologies hold enormous promise for farming and medicine economist.com/leaders/2025/0… from The Economist

Charles Spungen (@geographer847) 's Twitter Profile Photo

Really like this co., but recent trading pattern in $PRME often presages an offering. Still, diluted shares with a few extra hundred million in the bank are actually worth more.

Charles Spungen (@geographer847) 's Twitter Profile Photo

$prme Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy - Prime Medicine, Inc. Webcast November 12. 1) Top KOL for Wilson's 2) High confidence in liver delivery